Drug Approval | September 29, 2024
Briefs: Lupin, Alembic Pharmaceuticals and Piramal Pharma
Lupin's Pithampur Unit-1 gets Form 483 from USFDA with 3 observations
Lupin's Pithampur Unit-1 gets Form 483 from USFDA with 3 observations
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
Glenmark Pharmaceuticals Limited has informed that the USFDA has issued Form 483 with zero observations
Stable profits, low leverage to keep credit profiles comfortable
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
USFDA concludes inspection of Dr. Reddy's Laboratories R&D centre in Bachupally with zero observation
Coupled with Shea Butter, Cocoa Butter, and Mango Butter, the balm provides deep hydration, ensuring lips remain soft, smooth, and well-moisturized throughout the day
Target identification will commence on 17 September 2024, following the timeline provided in the campaign guidelines
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
Wanbury receives CEP approval from EDQM for launch of Dextromethorphan API
Subscribe To Our Newsletter & Stay Updated
